194 related articles for article (PubMed ID: 9804784)
1. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate.
Feron O; Dessy C; Opel DJ; Arstall MA; Kelly RA; Michel T
J Biol Chem; 1998 Nov; 273(46):30249-54. PubMed ID: 9804784
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic cholinergic signaling in cardiac myocytes: dynamic targeting of M2AChR to sarcolemmal caveolae and eNOS activation.
Feron O; Han X; Kelly RA
Life Sci; 1999; 64(6-7):471-7. PubMed ID: 10069512
[TBL] [Abstract][Full Text] [Related]
3. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes.
Feron O; Smith TW; Michel T; Kelly RA
J Biol Chem; 1997 Jul; 272(28):17744-8. PubMed ID: 9211926
[TBL] [Abstract][Full Text] [Related]
4. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.
Feron O; Michel JB; Sase K; Michel T
Biochemistry; 1998 Jan; 37(1):193-200. PubMed ID: 9425039
[TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells.
Feron O; Belhassen L; Kobzik L; Smith TW; Kelly RA; Michel T
J Biol Chem; 1996 Sep; 271(37):22810-4. PubMed ID: 8798458
[TBL] [Abstract][Full Text] [Related]
6. The endothelial nitric-oxide synthase-caveolin regulatory cycle.
Feron O; Saldana F; Michel JB; Michel T
J Biol Chem; 1998 Feb; 273(6):3125-8. PubMed ID: 9452418
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase.
Han X; Kubota I; Feron O; Opel DJ; Arstall MA; Zhao YY; Huang P; Fishman MC; Michel T; Kelly RA
Proc Natl Acad Sci U S A; 1998 May; 95(11):6510-5. PubMed ID: 9600997
[TBL] [Abstract][Full Text] [Related]
8. Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts.
Gödecke A; Heinicke T; Kamkin A; Kiseleva I; Strasser RH; Decking UK; Stumpe T; Isenberg G; Schrader J
J Physiol; 2001 Apr; 532(Pt 1):195-204. PubMed ID: 11368026
[TBL] [Abstract][Full Text] [Related]
9. Targeting and translocation of endothelial nitric oxide synthase.
Michel T
Braz J Med Biol Res; 1999 Nov; 32(11):1361-6. PubMed ID: 10559837
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of nitric oxide production by methylecgonidine in cultured neonatal rat cardiomyocytes.
Yang Y; Liao H; Ke Q; Cai J; Xiao YF; Morgan JP
Br J Pharmacol; 2002 Jan; 135(1):188-96. PubMed ID: 11786494
[TBL] [Abstract][Full Text] [Related]
11. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling.
Dessy C; Kelly RA; Balligand JL; Feron O
EMBO J; 2000 Aug; 19(16):4272-80. PubMed ID: 10944110
[TBL] [Abstract][Full Text] [Related]
12. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase.
Michel JB; Feron O; Sase K; Prabhakar P; Michel T
J Biol Chem; 1997 Oct; 272(41):25907-12. PubMed ID: 9325323
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo.
García-Cardeña G; Martasek P; Masters BS; Skidd PM; Couet J; Li S; Lisanti MP; Sessa WC
J Biol Chem; 1997 Oct; 272(41):25437-40. PubMed ID: 9325253
[TBL] [Abstract][Full Text] [Related]
14. Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytes.
Belhassen L; Feron O; Kaye DM; Michel T; Kelly RA
J Biol Chem; 1997 Apr; 272(17):11198-204. PubMed ID: 9111020
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexes.
Ostrom RS; Bundey RA; Insel PA
J Biol Chem; 2004 May; 279(19):19846-53. PubMed ID: 15007069
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity.
Ohsawa Y; Toko H; Katsura M; Morimoto K; Yamada H; Ichikawa Y; Murakami T; Ohkuma S; Komuro I; Sunada Y
Hum Mol Genet; 2004 Jan; 13(2):151-7. PubMed ID: 14645200
[TBL] [Abstract][Full Text] [Related]
18. The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes.
Feron O; Zhao YY; Kelly RA
Ann N Y Acad Sci; 1999 Jun; 874():11-9. PubMed ID: 10415516
[TBL] [Abstract][Full Text] [Related]
19. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand JL; Kelly RA; Marsden PA; Smith TW; Michel T
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):347-51. PubMed ID: 7678347
[TBL] [Abstract][Full Text] [Related]
20. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae.
Shaul PW; Smart EJ; Robinson LJ; German Z; Yuhanna IS; Ying Y; Anderson RG; Michel T
J Biol Chem; 1996 Mar; 271(11):6518-22. PubMed ID: 8626455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
